Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHA

finance.yahoo.com/news/gilead-sciences-inc-gild-kite-192657954.html

In This Article:
Gilead Sciences, Inc. (NASDAQ:GILD) plans to present over 20 research abstracts—spanning both Gilead and its cell therapy unit Kite—at two major medical conferences: the 2025 ASCO Annual Meeting (May 30–June 3) and the 2025 EHA Congress (June 12–15). The presentations…

This story appeared on finance.yahoo.com, 2025-05-18 19:26:57.
The Entire Business World on a Single Page. Free to Use →